Nanomedicine Market

Nanomedicine Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

149

Base Year:

2022

Jun - 2022

Format:

Report Code:

VMR-1632

Segments Covered

By Modality Diagnostics, Treatment
By Application Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, Others
By Indication Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 188.05 Billion
Revenue 2030:	USD 366.53 Billion
Revenue CAGR (2023 - 2030):	8.70%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Nanomedicine Market - Segment Analysis
1. Overview
2. Global Nanomedicine Market, 2016 - 2028 (USD Million)
3. Global Nanomedicine Market - by Modality
  1. By Diagnostics
  2. By Treatment
4. Global Nanomedicine Market - by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. Global Nanomedicine Market - by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. Global Nanomedicine Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Nanomedicine Market - Segment Analysis
1. Overview
2. North America Nanomedicine Market, 2016 - 2028 (USD Million)
3. North America Nanomedicine Market, by Modality
  1. By Diagnostics
  2. By Treatment
4. North America Nanomedicine Market, by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. North America Nanomedicine Market, by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. North America Nanomedicine Market, by Country
  1. U.S.
    1. U.S. Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. U.S. Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. U.S. Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  2. Canada
    1. Canada Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Canada Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Canada Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  3. Mexico
    1. Mexico Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Mexico Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Mexico Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
Europe Nanomedicine Market - Segment Analysis
1. Overview
2. Europe Nanomedicine Market, 2016 - 2028 (USD Million)
3. Europe Nanomedicine Market, by Modality
  1. By Diagnostics
  2. By Treatment
4. Europe Nanomedicine Market, by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. Europe Nanomedicine Market, by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. Europe Nanomedicine Market, by Country
  1. Germany
    1. Germany Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Germany Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Germany Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  2. UK
    1. UK Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. UK Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. UK Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  3. France
    1. France Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. France Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. France Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  4. Spain
    1. Spain Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Spain Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Spain Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  5. Italy
    1. Italy Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Italy Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Italy Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  6. BENELUX
    1. BENELUX Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. BENELUX Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. BENELUX Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  7. Rest of Europe
    1. Rest Of Europe Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Rest Of Europe Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Rest Of Europe Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
Asia Pacific Nanomedicine Market - Segment Analysis
1. Overview
2. Asia Pacific Nanomedicine Market, 2016 - 2028 (USD Million)
3. Asia Pacific Nanomedicine Market, by Modality
  1. By Diagnostics
  2. By Treatment
4. Asia Pacific Nanomedicine Market, by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. Asia Pacific Nanomedicine Market, by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. Asia Pacific Nanomedicine Market, by Country
  1. China
    1. China Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. China Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. China Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  2. Japan
    1. Japan Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Japan Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Japan Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  3. India
    1. India Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. India Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. India Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  4. South Korea
    1. South Korea Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. South Korea Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. South Korea Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  5. South East Asia
    1. South East Asia Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. South East Asia Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. South East Asia Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Rest of Asia Pacific Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Rest of Asia Pacific Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
Latin America Nanomedicine Market - Segment Analysis
1. Overview
2. Latin America Nanomedicine Market, 2016 - 2028 (USD Million)
3. Latin America Nanomedicine Market, by Modality
  1. By Diagnostics
  2. By Treatment
4. Latin America Nanomedicine Market, by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. Latin America Nanomedicine Market, by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. Latin America Nanomedicine Market, by Country
  1. Brazil
    1. Brazil Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Brazil Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Brazil Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  2. Argentina
    1. Argentina Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Argentina Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Argentina Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  3. Rest of Latin America
    1. Rest of Latin America Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Rest of Latin America Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Rest of Latin America Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
Middle East & Africa Nanomedicine Market - Segment Analysis
1. Overview
2. Middle East & Africa Nanomedicine Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Nanomedicine Market, by Modality
  1. By Diagnostics
  2. By Treatment
4. Middle East & Africa Nanomedicine Market, by Application
  1. By Drug Delivery
  2. By Diagnostic Imaging
  3. By Vaccines
  4. By Regenerative Medicine
  5. By Implants
  6. By Others
5. Middle East & Africa Nanomedicine Market, by Indication
  1. By Clinical Oncology
  2. By Infectious Diseases
  3. By Clinical Cardiology
  4. By Orthopedics
  5. By Neurology
  6. By Urology
  7. By Ophthalmology
  8. By Immunology
  9. By Others
6. Middle East & Africa Nanomedicine Market, by Country
  1. GCC Countries
    1. GCC Countries Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. GCC Countries Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. GCC Countries Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  2. South Africa
    1. South Africa Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. South Africa Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. South Africa Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Nanomedicine Market, By Modality
      1. By Diagnostics
      2. By Treatment
    2. Rest of Middle East & Africa Nanomedicine Market, By Application
      1. By Drug Delivery
      2. By Diagnostic Imaging
      3. By Vaccines
      4. By Regenerative Medicine
      5. By Implants
      6. By Others
    3. Rest of Middle East & Africa Nanomedicine Market, By Indication
      1. By Clinical Oncology
      2. By Infectious Diseases
      3. By Clinical Cardiology
      4. By Orthopedics
      5. By Neurology
      6. By Urology
      7. By Ophthalmology
      8. By Immunology
      9. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Abbott Laboratories
2. DiaSorin S.P.A.
3. General Electric Company
4. Invitae Corporation
5. Johnson & Johnson
6. Leadient BioSciences Inc.
7. Mallinckrodt PLC
8. Merck & Co. Inc. Pfizer Inc.
9. Teva Pharmaceuticals Ltd.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 06-Jun-2022

Nanomedicine Market to Reach Valuation of USD 288.7 Billion by 2028 - Increasing Demand for Nanomedicine Market for Drug Delivery, Advantages of Nanomedicine in Various Healthcare Applications, and Growth in Need for Safe and Cost-Effective Therapies to Drive the Market Growth

FAQ

Frequently Asked Question

What is the global demand for Nanomedicine in terms of revenue?

The global Nanomedicine valued at USD 188.05 Billion in 2022 and is expected to reach USD 366.53 Billion in 2030 growing at a CAGR of 8.70%.

Which are the prominent players in the market?

The prominent players in the market are Abbott Laboratories, DiaSorin S.P.A., General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences Inc., Mallinckrodt PLC, Merck & Co. Inc. Pfizer Inc., Teva Pharmaceuticals Ltd..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 8.70% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Nanomedicine include
- Rising level of government participation in R&D funding

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Nanomedicine in 2022.

Nanomedicine Market

Nanomedicine Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Nanomedicine in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Nanomedicine Market

Nanomedicine Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Nanomedicine in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Nanomedicine Market

Vantage Point Interactive Dashboard